To achieve long term total return by investing, directly or indirectly (including through QFII, RQFII, the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programmes, participatory notes, equity linked notes and any other eligible means), at least two-thirds of its total assets in equity and equity-related securities of companies whose securities are listed on Chinese Stock Exchanges, including, without limitation, China A-Shares and B-Shares of companies listed on the Chinese Stock Exchanges or other equivalent securities authorised by the China Securities Regulatory Commission for purchase by non-Chinese investors. The Fund is actively managed. The Fund aims to outperform the MSCI China A Index (USD) benchmark before charges. The benchmark is also used as a reference point for portfolio construction and as a basis for setting risk constraints. In order to achieve its objective, the Fund will take positions whose weightings diverge from the benchmark or invest in securities which are not included in the benchmark.
Fees and Expenses
Fund's portfolio distribution among the different geographical areas.
|United States of America||0,52%|
Fund's investments distribution.
|Kweichow Moutai Co Ltd Ord||7,40%|
|China Tourism Group Duty Free Corp Ltd Ord||5,04%|
|Centre Testing International Group Co Ltd Ord||3,63%|
|Contemporary Amperex Technology Co Ltd Ord||3,61%|
|Shenzhen Mindray Bio-medical Electronics Co Ltd Or||3,39%|
|Longi Green Energy Technology Co Ltd Ord||3,37%|
|Glodon Co Ltd Ord||3,31%|
|China Merchants Bank Co Ltd Ord||3,04%|
|Midea Group Co Ltd Ord||2,99%|
|Aier Eye Hospital Group Co Ltd Ord||2,93%|
Fund's possitions distribution by the sdctor they belong to.